BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33146828)

  • 1. IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas.
    Di Napoli A; Greco D; Scafetta G; Ascenzi F; Gulino A; Aurisicchio L; Santanelli Di Pompeo F; Bonifacino A; Giarnieri E; Morgan J; Mancini R; Kadin ME
    Cancer Immunol Immunother; 2021 May; 70(5):1379-1392. PubMed ID: 33146828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytological diagnostic features of late breast implant seromas: From reactive to anaplastic large cell lymphoma.
    Di Napoli A; Pepe G; Giarnieri E; Cippitelli C; Bonifacino A; Mattei M; Martelli M; Falasca C; Cox MC; Santino I; Giovagnoli MR
    PLoS One; 2017; 12(7):e0181097. PubMed ID: 28715445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytological Diagnosis of Bilateral Breast Implant-Associated Lymphoma of the ALK-Negative Anaplastic Large-Cell Type. Clinical Implications of Peri-Implant Breast Seroma Cytological Reporting.
    Granados R; Lumbreras EM; Delgado M; Aramburu JA; Tardío JC
    Diagn Cytopathol; 2016 Jul; 44(7):623-7. PubMed ID: 27079579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Analysis of Cytokines of Tumor Cell Lines, Malignant and Benign Effusions Around Breast Implants.
    Kadin ME; Morgan J; Kouttab N; Xu H; Adams WP; Glicksman C; McGuire P; Sieber D; Epstein AL; Miranda RN; Clemens MW
    Aesthet Surg J; 2020 May; 40(6):630-637. PubMed ID: 31589747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of breast implant associated  anaplastic large cell lymphoma by analysis of cytokines in peri-implant seromas.
    Hu H; Shklovskaya E; Deva A; Xu H; Fan K; Brosamer K; Willson R; Khan I; Sinha M; Kadin ME
    Am J Hematol; 2023 Nov; 98(11):E312-E314. PubMed ID: 37646570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
    Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Implications and Management of Non-BIA-ALCL Breast Implant Capsular Pathology.
    Vorstenbosch J; Chu JJ; Ariyan CE; McCarthy CM; Disa JJ; Nelson JA
    Plast Reconstr Surg; 2023 Jan; 151(1):20e-30e. PubMed ID: 36194076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving Reliable Diagnosis in Late Breast Implant Seromas: From Reactive to Anaplastic Large Cell Lymphoma.
    Di Napoli A
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):15S-22S. PubMed ID: 30817552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of flow cytometry and cytology to differentiate breast implant-associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients.
    De Azambuja AP; Gevert F; Oliveira RM; Sebastião AP; Groth AK
    Cytometry B Clin Cytom; 2022 Jul; 102(4):312-316. PubMed ID: 34791787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD30 Lateral Flow and Enzyme-Linked Immunosorbent Assays for Detection of BIA-ALCL: A Pilot Study.
    Zeyl VG; Xu H; Khan I; Machan JT; Clemens MW; Hu H; Deva A; Glicksman C; McGuire P; Adams WP; Sieber D; Sinha M; Kadin ME
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    Kadin ME
    Aesthet Surg J; 2019 Jan; 39(Suppl_1):S28-S35. PubMed ID: 30715174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable presentation of anaplastic large-cell lymphoma in patients with breast implants.
    Locke MB; Lofts J
    ANZ J Surg; 2017 Oct; 87(10):789-794. PubMed ID: 25827224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anaplastic large-cell lymphoma associated with breast implants: a unique entity within the spectrum of peri-implant effusions.
    Chai SM; Kavangh S; Ooi SS; Sterrett GF; Cull G; Plunkett M; Spagnolo D; Amanuel B; Joske D; Leslie C; Barham T; Frost F
    Diagn Cytopathol; 2014 Nov; 42(11):929-38. PubMed ID: 24687769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
    Kadin ME; Adams WP; Inghirami G; Di Napoli A
    Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Kadin ME; Morgan J; Xu H; Glicksman CA
    Aesthet Surg J; 2017 Jul; 37(7):771-775. PubMed ID: 28402493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Kadin ME; Morgan J; Wei W; Song Z; Yang Y
    Aesthet Surg J; 2023 Feb; 43(2):137-146. PubMed ID: 35999655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
    Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
    Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of Anaplastic Large-Cell Lymphoma (ALCL) in Cases of Late Seroma Formation After Breast Implant Insertion.
    Hwang K; Kim H; Kim HM; Kim JH
    Eplasty; 2021; 21():e4. PubMed ID: 33747338
    [No Abstract]   [Full Text] [Related]  

  • 19. New insights into breast implant-associated anaplastic large cell lymphoma.
    Laurent C; Haioun C; Brousset P; Gaulard P
    Curr Opin Oncol; 2018 Sep; 30(5):292-300. PubMed ID: 30096095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granzyme B Is a Biomarker for Suspicion of Malignant Seromas Around Breast Implants.
    Kadin ME; Morgan J; Xu H; Glicksman C; Sieber D; Adams WP; McGuire P; Clemens MW; Thakur A; Lum LG
    Aesthet Surg J; 2021 Nov; 41(12):1359-1364. PubMed ID: 33165542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.